AZR-MD-001 0.5% selenium sulfide ophthalmic ointment for the treatment of contact lens discomfort: A vehicle-controlled, randomized, clinical trial.

Stapleton F, Hinds M, Tan J, Jones L, Chalmers R, Bosworth C, Alster Y.

Open source

DOI
10.1016/j.jtos.2024.12.009
Published
2024-12-28
Container
Ocul Surf
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jtos.2024.12.009,
  title = {AZR-MD-001 0.5\% selenium sulfide ophthalmic ointment for the treatment of contact lens discomfort: A vehicle-controlled, randomized, clinical trial.},
  author = {Stapleton F and  Hinds M and  Tan J and  Jones L and  Chalmers R and  Bosworth C and  Alster Y.},
  year = {2025},
  journal = {Ocul Surf},
  doi = {10.1016/j.jtos.2024.12.009},
  url = {https://doi.org/10.1016/j.jtos.2024.12.009}
}

RIS

TY  - JOUR
TI  - AZR-MD-001 0.5% selenium sulfide ophthalmic ointment for the treatment of contact lens discomfort: A vehicle-controlled, randomized, clinical trial.
AU  - Stapleton F
AU  -  Hinds M
AU  -  Tan J
AU  -  Jones L
AU  -  Chalmers R
AU  -  Bosworth C
AU  -  Alster Y.
PY  - 2025
JO  - Ocul Surf
DO  - 10.1016/j.jtos.2024.12.009
UR  - https://doi.org/10.1016/j.jtos.2024.12.009
ER  - 

APA

F, S., M, H., J, T., L, J., R, C., C, B., & Y., A. (2025). AZR-MD-001 0.5% selenium sulfide ophthalmic ointment for the treatment of contact lens discomfort: A vehicle-controlled, randomized, clinical trial.. Ocul Surf. https://doi.org/10.1016/j.jtos.2024.12.009

Source records